APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pimozide

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Selected research

Market Analysis & Forecast

Global Pimozide Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchPimozide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pimozide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pimozide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pimozide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pimozide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.

North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.

Read the full market overview

In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.

This report presents an overview of global market for Pimozide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pimozide, also provides the sales of main regions and countries. Of the upcoming market potential for Pimozide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pimozide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pimozide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pimozide sales, projected growth trends, production technology, application and end-user industry.

Pimozide Segment by Company

Teva

Par Pharmaceutical

Johnson & Johnson

Eumedica

Pharmascience

Domina Pharmaceuticals

Aa Pharma

Pimozide Segment by Type

1Mg

2Mg

4Mg

Pimozide Segment by Application

Hospitals

Drugstores

Others

Pimozide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimozide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pimozide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimozide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pimozide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pimozide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pimozide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1Mg Major Manufacturers Table 3. 2Mg Major Manufacturers Table 4. 4Mg Major Manufacturers Table 5. Global Pimozide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Drugstores Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pimozide Industry Trends Table 10. Pimozide Industry Drivers Table 11. Pimozide Industry Opportunities and Challenges Table 12. Pimozide Industry Restraints Table 13. Global Pimozide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pimozide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pimozide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pimozide Revenue Market Share by Region (2021-2026) Table 17. Global Pimozide Revenue Market Share by Region (2027-2032) Table 18. Global Pimozide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pimozide Sales by Region (2021-2026) & (K Units) Table 20. Global Pimozide Sales by Region (2027-2032) & (K Units) Table 21. Global Pimozide Sales Market Share by Region (2021-2026) Table 22. Global Pimozide Sales Market Share by Region (2027-2032) Table 23. Global Pimozide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pimozide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pimozide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pimozide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pimozide Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Pimozide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pimozide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pimozide Manufacturers, Product Type & Application Table 31. Global Pimozide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pimozide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pimozide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pimozide Revenue Market Share by Type (2021-2026) Table 38. Global Pimozide Revenue Market Share by Type (2027-2032) Table 39. Global Pimozide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Pimozide Sales by Type (2021-2026) & (K Units) Table 41. Global Pimozide Sales by Type (2027-2032) & (K Units) Table 42. Global Pimozide Sales Market Share by Type (2021-2026) Table 43. Global Pimozide Sales Market Share by Type (2027-2032) Table 44. Global Pimozide Price by Type (2021-2026) & (USD/Unit) Table 45. Global Pimozide Price by Type (2027-2032) & (USD/Unit) Table 46. Global Pimozide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pimozide Revenue Market Share by Application (2021-2026) Table 50. Global Pimozide Revenue Market Share by Application (2027-2032) Table 51. Global Pimozide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Pimozide Sales by Application (2021-2026) & (K Units) Table 53. Global Pimozide Sales by Application (2027-2032) & (K Units) Table 54. Global Pimozide Sales Market Share by Application (2021-2026) Table 55. Global Pimozide Sales Market Share by Application (2027-2032) Table 56. Global Pimozide Price by Application (2021-2026) & (USD/Unit) Table 57. Global Pimozide Price by Application (2027-2032) & (USD/Unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Teva Pimozide Product Portfolio Table 62. Teva Recent Development Table 63. Par Pharmaceutical Company Information Table 64. Par Pharmaceutical Business Overview Table 65. Par Pharmaceutical Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Par Pharmaceutical Pimozide Product Portfolio Table 67. Par Pharmaceutical Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Pimozide Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Eumedica Company Information Table 74. Eumedica Business Overview Table 75. Eumedica Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Eumedica Pimozide Product Portfolio Table 77. Eumedica Recent Development Table 78. Pharmascience Company Information Table 79. Pharmascience Business Overview Table 80. Pharmascience Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Pharmascience Pimozide Product Portfolio Table 82. Pharmascience Recent Development Table 83. Domina Pharmaceuticals Company Information Table 84. Domina Pharmaceuticals Business Overview Table 85. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Domina Pharmaceuticals Pimozide Product Portfolio Table 87. Domina Pharmaceuticals Recent Development Table 88. Aa Pharma Company Information Table 89. Aa Pharma Business Overview Table 90. Aa Pharma Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Aa Pharma Pimozide Product Portfolio Table 92. Aa Pharma Recent Development Table 93. North America Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Pimozide Sales by Type (2021-2026) & (K Units) Table 96. North America Pimozide Sales by Type (2027-2032) & (K Units) Table 97. North America Pimozide Sales Price by Type (2021-2026) & (USD/Unit) Table 98. North America Pimozide Sales Price by Type (2027-2032) & (USD/Unit) Table 99. North America Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Pimozide Sales by Application (2021-2026) & (K Units) Table 102. North America Pimozide Sales by Application (2027-2032) & (K Units) Table 103. North America Pimozide Sales Price by Application (2021-2026) & (USD/Unit) Table 104. North America Pimozide Sales Price by Application (2027-2032) & (USD/Unit) Table 105. North America Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Pimozide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Pimozide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Pimozide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Pimozide Sales by Country (2021-2026) & (K Units) Table 110. North America Pimozide Sales by Country (2027-2032) & (K Units) Table 111. North America Pimozide Sales Price by Country (2021-2026) & (USD/Unit) Table 112. North America Pimozide Sales Price by Country (2027-2032) & (USD/Unit) Table 113. United States Pimozide Revenue (2021-2032) & (US$ Million) Table 114. Canada Pimozide Revenue (2021-2032) & (US$ Million) Table 115. Mexico Pimozide Revenue (2021-2032) & (US$ Million) Table 116. Europe Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Pimozide Sales by Type (2021-2026) & (K Units) Table 119. Europe Pimozide Sales by Type (2027-2032) & (K Units) Table 120. Europe Pimozide Sales Price by Type (2021-2026) & (USD/Unit) Table 121. Europe Pimozide Sales Price by Type (2027-2032) & (USD/Unit) Table 122. Europe Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Pimozide Sales by Application (2021-2026) & (K Units) Table 125. Europe Pimozide Sales by Application (2027-2032) & (K Units) Table 126. Europe Pimozide Sales Price by Application (2021-2026) & (USD/Unit) Table 127. Europe Pimozide Sales Price by Application (2027-2032) & (USD/Unit) Table 128. Europe Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Pimozide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Pimozide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Pimozide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe Pimozide Sales by Country (2021-2026) & (K Units) Table 133. Europe Pimozide Sales by Country (2027-2032) & (K Units) Table 134. Europe Pimozide Sales Price by Country (2021-2026) & (USD/Unit) Table 135. Europe Pimozide Sales Price by Country (2027-2032) & (USD/Unit) Table 136. Germany Pimozide Revenue (2021-2032) & (US$ Million) Table 137. France Pimozide Revenue (2021-2032) & (US$ Million) Table 138. U.K. Pimozide Revenue (2021-2032) & (US$ Million) Table 139. Italy Pimozide Revenue (2021-2032) & (US$ Million) Table 140. Russia Pimozide Revenue (2021-2032) & (US$ Million) Table 141. Spain Pimozide Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Pimozide Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Pimozide Revenue (2021-2032) & (US$ Million) Table 144. Sweden Pimozide Revenue (2021-2032) & (US$ Million) Table 145. Poland Pimozide Revenue (2021-2032) & (US$ Million) Table 146. China Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 147. China Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 148. China Pimozide Sales by Type (2021-2026) & (K Units) Table 149. China Pimozide Sales by Type (2027-2032) & (K Units) Table 150. China Pimozide Sales Price by Type (2021-2026) & (USD/Unit) Table 151. China Pimozide Sales Price by Type (2027-2032) & (USD/Unit) Table 152. China Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 153. China Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 154. China Pimozide Sales by Application (2021-2026) & (K Units) Table 155. China Pimozide Sales by Application (2027-2032) & (K Units) Table 156. China Pimozide Sales Price by Application (2021-2026) & (USD/Unit) Table 157. China Pimozide Sales Price by Application (2027-2032) & (USD/Unit) Table 158. Asia Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Pimozide Sales by Type (2021-2026) & (K Units) Table 161. Asia Pimozide Sales by Type (2027-2032) & (K Units) Table 162. Asia Pimozide Sales Price by Type (2021-2026) & (USD/Unit) Table 163. Asia Pimozide Sales Price by Type (2027-2032) & (USD/Unit) Table 164. Asia Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Pimozide Sales by Application (2021-2026) & (K Units) Table 167. Asia Pimozide Sales by Application (2027-2032) & (K Units) Table 168. Asia Pimozide Sales Price by Application (2021-2026) & (USD/Unit) Table 169. Asia Pimozide Sales Price by Application (2027-2032) & (USD/Unit) Table 170. Asia Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Pimozide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Pimozide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Pimozide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Pimozide Sales by Country (2021-2026) & (K Units) Table 175. Asia Pimozide Sales by Country (2027-2032) & (K Units) Table 176. Asia Pimozide Sales Price by Country (2021-2026) & (USD/Unit) Table 177. Asia Pimozide Sales Price by Country (2027-2032) & (USD/Unit) Table 178. Japan Pimozide Revenue (2021-2032) & (US$ Million) Table 179. South Korea Pimozide Revenue (2021-2032) & (US$ Million) Table 180. India Pimozide Revenue (2021-2032) & (US$ Million) Table 181. Australia Pimozide Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Pimozide Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Pimozide Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Pimozide Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Pimozide Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Pimozide Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Pimozide Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Pimozide Sales Price by Type (2021-2026) & (USD/Unit) Table 189. SAMEA Pimozide Sales Price by Type (2027-2032) & (USD/Unit) Table 190. SAMEA Pimozide Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Pimozide Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Pimozide Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Pimozide Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Pimozide Sales Price by Application (2021-2026) & (USD/Unit) Table 195. SAMEA Pimozide Sales Price by Application (2027-2032) & (USD/Unit) Table 196. SAMEA Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Pimozide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Pimozide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Pimozide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Pimozide Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Pimozide Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Pimozide Sales Price by Country (2021-2026) & (USD/Unit) Table 203. SAMEA Pimozide Sales Price by Country (2027-2032) & (USD/Unit) Table 204. Brazil Pimozide Revenue (2021-2032) & (US$ Million) Table 205. Argentina Pimozide Revenue (2021-2032) & (US$ Million) Table 206. Chile Pimozide Revenue (2021-2032) & (US$ Million) Table 207. Colombia Pimozide Revenue (2021-2032) & (US$ Million) Table 208. Peru Pimozide Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Pimozide Revenue (2021-2032) & (US$ Million) Table 210. Israel Pimozide Revenue (2021-2032) & (US$ Million) Table 211. UAE Pimozide Revenue (2021-2032) & (US$ Million) Table 212. Turkey Pimozide Revenue (2021-2032) & (US$ Million) Table 213. Iran Pimozide Revenue (2021-2032) & (US$ Million) Table 214. Egypt Pimozide Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Pimozide Distributors List Table 218. Pimozide Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Pimozide Image Figure 2. Global Pimozide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pimozide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1Mg Image Figure 5. 2Mg Image Figure 6. 4Mg Image Figure 7. Global Pimozide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pimozide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Drugstores Image Figure 11. Others Image Figure 12. Global Pimozide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pimozide Revenue (2021-2032) & (US$ Million) Figure 14. Global Pimozide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pimozide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pimozide Revenue Market Share by Region (2021-2032) Figure 17. Global Pimozide Sales (2021-2032) & (K Units) Figure 18. Global Pimozide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Pimozide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pimozide Sales YoY (2021-2032) & (K Units) Figure 21. Europe Pimozide Sales YoY (2021-2032) & (K Units) Figure 22. China Pimozide Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Pimozide Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Pimozide Sales YoY (2021-2032) & (K Units) Figure 25. Global Pimozide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pimozide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pimozide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pimozide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pimozide Revenue Market Share by Type (2021-2032) Figure 31. Global Pimozide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Pimozide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pimozide Sales Market Share by Type (2021-2032) Figure 34. Global Pimozide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pimozide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pimozide Revenue Market Share by Application (2021-2032) Figure 37. Global Pimozide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Pimozide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pimozide Sales Market Share by Application (2021-2032) Figure 40. North America Pimozide Revenue Share by Type (2021-2032) Figure 41. North America Pimozide Sales Share by Type (2021-2032) Figure 42. North America Pimozide Revenue Share by Application (2021-2032) Figure 43. North America Pimozide Sales Share by Application (2021-2032) Figure 44. North America Pimozide Revenue Share by Country (2021-2032) Figure 45. North America Pimozide Sales Share by Country (2021-2032) Figure 46. Europe Pimozide Revenue Share by Type (2021-2032) Figure 47. Europe Pimozide Sales Share by Type (2021-2032) Figure 48. Europe Pimozide Revenue Share by Application (2021-2032) Figure 49. Europe Pimozide Sales Share by Application (2021-2032) Figure 50. Europe Pimozide Revenue Share by Country (2021-2032) Figure 51. Europe Pimozide Sales Share by Country (2021-2032) Figure 52. China Pimozide Revenue Share by Type (2021-2032) Figure 53. China Pimozide Sales Share by Type (2021-2032) Figure 54. China Pimozide Revenue Share by Application (2021-2032) Figure 55. China Pimozide Sales Share by Application (2021-2032) Figure 56. Asia Pimozide Revenue Share by Type (2021-2032) Figure 57. Asia Pimozide Sales Share by Type (2021-2032) Figure 58. Asia Pimozide Revenue Share by Application (2021-2032) Figure 59. Asia Pimozide Sales Share by Application (2021-2032) Figure 60. Asia Pimozide Revenue Share by Country (2021-2032) Figure 61. Asia Pimozide Sales Share by Country (2021-2032) Figure 62. SAMEA Pimozide Revenue Share by Type (2021-2032) Figure 63. SAMEA Pimozide Sales Share by Type (2021-2032) Figure 64. SAMEA Pimozide Revenue Share by Application (2021-2032) Figure 65. SAMEA Pimozide Sales Share by Application (2021-2032) Figure 66. SAMEA Pimozide Revenue Share by Country (2021-2032) Figure 67. SAMEA Pimozide Sales Share by Country (2021-2032) Figure 68. Pimozide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pimozide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 1Mg
  • 2Mg
  • 4Mg
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • Teva
  • Par Pharmaceutical
  • Johnson & Johnson
  • Eumedica
  • Pharmascience
  • Domina Pharmaceuticals
  • Aa Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pimozide Market by Type
  3. 1.2.1 Global Pimozide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1Mg
  5. 1.2.3 2Mg
  6. 1.2.4 4Mg
  7. 1.3 Pimozide Market by Application
  8. 1.3.1 Global Pimozide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Drugstores
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pimozide Market Dynamics
  1. 2.1 Pimozide Industry Trends
  2. 2.2 Pimozide Industry Drivers
  3. 2.3 Pimozide Industry Opportunities and Challenges
  4. 2.4 Pimozide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pimozide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pimozide Revenue by Region
  3. 3.2.1 Global Pimozide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pimozide Revenue by Region (2021-2026)
  5. 3.2.3 Global Pimozide Revenue by Region (2027-2032)
  6. 3.2.4 Global Pimozide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pimozide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pimozide Sales by Region
  9. 3.4.1 Global Pimozide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pimozide Sales by Region (2021-2026)
  11. 3.4.3 Global Pimozide Sales by Region (2027-2032)
  12. 3.4.4 Global Pimozide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pimozide Revenue by Manufacturers
  2. 4.1.1 Global Pimozide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pimozide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pimozide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pimozide Sales by Manufacturers
  6. 4.2.1 Global Pimozide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pimozide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pimozide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pimozide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pimozide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pimozide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pimozide Manufacturers, Product Type & Application
  13. 4.7 Global Pimozide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pimozide Market CR5 and HHI
  16. 4.8.2 2025 Pimozide Tier 1, Tier 2, and Tier 3
5 Pimozide Market by Type
  1. 5.1 Global Pimozide Revenue by Type
  2. 5.1.1 Global Pimozide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pimozide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pimozide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pimozide Sales by Type
  6. 5.2.1 Global Pimozide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pimozide Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pimozide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pimozide Price by Type
6 Pimozide Market by Application
  1. 6.1 Global Pimozide Revenue by Application
  2. 6.1.1 Global Pimozide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pimozide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pimozide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pimozide Sales by Application
  6. 6.2.1 Global Pimozide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pimozide Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pimozide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pimozide Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pimozide Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Par Pharmaceutical
  8. 7.2.1 Par Pharmaceutical Company Information
  9. 7.2.2 Par Pharmaceutical Business Overview
  10. 7.2.3 Par Pharmaceutical Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Par Pharmaceutical Pimozide Product Portfolio
  12. 7.2.5 Par Pharmaceutical Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Pimozide Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Eumedica
  20. 7.4.1 Eumedica Company Information
  21. 7.4.2 Eumedica Business Overview
  22. 7.4.3 Eumedica Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eumedica Pimozide Product Portfolio
  24. 7.4.5 Eumedica Recent Developments
  25. 7.5 Pharmascience
  26. 7.5.1 Pharmascience Company Information
  27. 7.5.2 Pharmascience Business Overview
  28. 7.5.3 Pharmascience Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pharmascience Pimozide Product Portfolio
  30. 7.5.5 Pharmascience Recent Developments
  31. 7.6 Domina Pharmaceuticals
  32. 7.6.1 Domina Pharmaceuticals Company Information
  33. 7.6.2 Domina Pharmaceuticals Business Overview
  34. 7.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
  36. 7.6.5 Domina Pharmaceuticals Recent Developments
  37. 7.7 Aa Pharma
  38. 7.7.1 Aa Pharma Company Information
  39. 7.7.2 Aa Pharma Business Overview
  40. 7.7.3 Aa Pharma Pimozide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Aa Pharma Pimozide Product Portfolio
  42. 7.7.5 Aa Pharma Recent Developments
8 North America
  1. 8.1 North America Pimozide Market Size by Type
  2. 8.1.1 North America Pimozide Revenue by Type (2021-2032)
  3. 8.1.2 North America Pimozide Sales by Type (2021-2032)
  4. 8.1.3 North America Pimozide Price by Type (2021-2032)
  5. 8.2 North America Pimozide Market Size by Application
  6. 8.2.1 North America Pimozide Revenue by Application (2021-2032)
  7. 8.2.2 North America Pimozide Sales by Application (2021-2032)
  8. 8.2.3 North America Pimozide Price by Application (2021-2032)
  9. 8.3 North America Pimozide Market Size by Country
  10. 8.3.1 North America Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pimozide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pimozide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pimozide Market Size by Type
  2. 9.1.1 Europe Pimozide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pimozide Sales by Type (2021-2032)
  4. 9.1.3 Europe Pimozide Price by Type (2021-2032)
  5. 9.2 Europe Pimozide Market Size by Application
  6. 9.2.1 Europe Pimozide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pimozide Sales by Application (2021-2032)
  8. 9.2.3 Europe Pimozide Price by Application (2021-2032)
  9. 9.3 Europe Pimozide Market Size by Country
  10. 9.3.1 Europe Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pimozide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pimozide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pimozide Market Size by Type
  2. 10.1.1 China Pimozide Revenue by Type (2021-2032)
  3. 10.1.2 China Pimozide Sales by Type (2021-2032)
  4. 10.1.3 China Pimozide Price by Type (2021-2032)
  5. 10.2 China Pimozide Market Size by Application
  6. 10.2.1 China Pimozide Revenue by Application (2021-2032)
  7. 10.2.2 China Pimozide Sales by Application (2021-2032)
  8. 10.2.3 China Pimozide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pimozide Market Size by Type
  2. 11.1.1 Asia Pimozide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pimozide Sales by Type (2021-2032)
  4. 11.1.3 Asia Pimozide Price by Type (2021-2032)
  5. 11.2 Asia Pimozide Market Size by Application
  6. 11.2.1 Asia Pimozide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pimozide Sales by Application (2021-2032)
  8. 11.2.3 Asia Pimozide Price by Application (2021-2032)
  9. 11.3 Asia Pimozide Market Size by Country
  10. 11.3.1 Asia Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pimozide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pimozide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pimozide Market Size by Type
  2. 12.1.1 SAMEA Pimozide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pimozide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pimozide Price by Type (2021-2032)
  5. 12.2 SAMEA Pimozide Market Size by Application
  6. 12.2.1 SAMEA Pimozide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pimozide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pimozide Price by Application (2021-2032)
  9. 12.3 SAMEA Pimozide Market Size by Country
  10. 12.3.1 SAMEA Pimozide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pimozide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pimozide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pimozide Value Chain Analysis
  2. 13.1.1 Pimozide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pimozide Production Mode & Process
  6. 13.2 Pimozide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pimozide Distributors
  9. 13.2.3 Pimozide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst